BRENNA FITZGERALD: Open Payments
NPI 1437337110 · NORTH LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,283 in 148 payments from 25 companies in 2025. Trend: 2023 $2,589 · 2024 $2,890 · 2025 $4,283
Food & beverage: $2,773Consulting: $1,510
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $1,411 |
| TG Therapeutics, Inc. | 30 | $598 |
| ABBVIE INC. | 27 | $412 |
| PFIZER INC. | 22 | $311 |
| Biogen, Inc. | 7 | $295 |
| Eisai Inc. | 2 | $150 |
| Novartis Pharmaceuticals Corporation | 10 | $147 |
| Celgene Corporation | 8 | $145 |
| Amneal Pharmaceuticals LLC | 5 | $119 |
| Lilly USA, LLC | 4 | $74 |
Products named: BRIUMVI, NURTEC ODT, QULIPTA, TYSABRI, Leqembi, KESIMPTA, ZEPOSIA, VUMERITY.
Industry payments across AR — which companies pay providers there.
